Opioid receptor modulator dosage formulations | Patent Publication Number 20140271854

US 20140271854 A1
Patent NumberUS 09675587 B2
Application Number13829984
Filled DateMar 14, 2013
Priority DateMar 14, 2013
Publication DateSep 18, 2014
Original AssigneeAbbvie Inc.
Furiex Pharmaceuticals Inc.
Current AssigneeAllergan Holdings France S.a.s.
Inventor/ApplicantsJens Jozef Ceulemans
Tim Costello
Philip Erna H. Heyns
Eugeen Maria Jozef Jans
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.